|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.00 EUR | -.--% |
|
-.--% | - |
| 24/09/25 | PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 11/09/25 | PharmaSGP Holding SE Reaffirms Earnings Guidance for the Financial Year 2025 | CI |
| 1 year | 28.6 |  | 29.4 |
| 3 years | 17.7 | | 30 |
| 5 years | 17.7 | | 30 |
| 10 years | 14.4 | | 36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 01/01/2025 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 04/03/2020 |
| Director/Board Member | 45 | 04/03/2020 | |
Axel Rebien
BRD | Director/Board Member | 55 | 01/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 447M | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| +0.68% | -1.14% | +38.47% | +33.36% | 350B | |
| -1.66% | -3.13% | +32.18% | +39.79% | 292B | |
| -8.96% | -10.77% | +3.57% | +5.50% | 239B | |
| -1.37% | -7.41% | -2.10% | -43.67% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| Average | -1.38% | -3.88% | +26.70% | +48.45% | 388.94B | |
| Weighted average by Cap. | -0.93% | -4.34% | +34.73% | +70.96% |
Employees
98
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PSG Stock
- PSG Stock
Select your edition
All financial news and data tailored to specific country editions
